Article Text

Download PDFPDF
EP1285 Pregnancy and epithelial ovarian cancer: case report
  1. O Puentes1,
  2. T Quijano2,
  3. E Mora1 and
  4. C Rojas1
  1. 1Fundación Universitaria de Ciencias de la Salud
  2. 2FUCS, Fundación Universitaria de Ciencias de la Salud, Colombia, Colombia


Introduction/Background Epithelial ovarian cancer in pregnant patients, an uncommon problem, delay maternity increases frequency. Pregnancy patient 18 5/7 weeks and a complex adnexal mass of 13 centimeters and elevated tumor markers is found. In surgery on 20 weeks, abdominal-pelvic mass is found diagnosing epithelial ovarian cancer Our aim was to present the case of a pregnant patient with and epithelial ovarian cancer and review the literature concerned.

Methodology We present the case of a patient with a pregnancy of 18 weeks of gestation and mucinous epithelial cáncer.

Results The diagnosis is difficult, pregnancy characteristic symptoms create distractions. The tumor markers have limited value. Human epididymal protein 4 may have utility in diagnosis and management Ultrasound is the preferred tool, because of its high sensitivity and specificity. Magnetic resonance imaging is performed on masses suggestive of malignancy, the use of contrast and computerized axial tomography is discouraged. It is recommended to treat the pregnant patient as well as the non-pregnant patient. Adjuvant chemotherapy is administered with greater security during the second and third trimester, suspended three weeks before delivery, to avoid fetal myelosuppression The oncological outcome is not conclusive. This increases fetal losses, prematurity and fetal growth restriction. The patient pregnancy is interrupted by cesarean, on week 32, a male newborn of 1645 g is received with apgar 8–9–9 and the oncological surgery is completed.

Conclusion Epithelial ovarian cancer in pregnancy is rare, there is a clear lack of information. The diagnosis, surgical and adjuvant treatment should be performed in the same way as a non-pregnant patient. The surgical approach and chemotherapy are recommended in the second and third trimesters. Oncological results are like non-pregnant patients. Fetal results are encouraging.

Disclosure Nothing to disclose

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.